GASTROINTESTINAL NEUROENDOCRINE TUMORS
Clinical trials for GASTROINTESTINAL NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive drug targets Hard-to-Treat gut and adrenal tumors
Disease control Recruiting nowThis study tests a new radioactive drug, [212Pb]VMT-alpha-NET, in people with advanced gastrointestinal neuroendocrine tumors or pheochromocytoma/paragangliomas that have already been treated with radiation therapy. The drug is designed to attach to a protein on the surface of th…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMORS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New radiation drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a radioactive drug that seeks out and delivers radiation directly to cancer cells with a specific protein (somatostatin receptor). It is for adults with advanced lung, kidney, head and neck, digestive tract, or adrenal gland tumors that cannot be remo…
Matched conditions: GASTROINTESTINAL NEUROENDOCRINE TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC